Pancreatitis

58 Pancreatitis




Overview/pathophysiology


The pancreas serves both endocrine (hormonal) and exocrine (nonhormonal) functions. (Pancreatic endocrine function is discussed in “Diabetes Mellitus,” p. 348.) The exocrine portion comprises 98% of its tissue mass. Exocrine secretions, which are produced by the acini cells, empty through a series of lobular ducts into the main pancreatic duct, where they are released into the duodenum. Exocrine function is the secretion of potent enzymes, proteases, lipases, and amylases that act to reduce proteins, fats, and carbohydrates respectively into simpler chemical substances. Pancreatic proteases (trypsin, chymotrypsin, carboxypeptidases A and B, elastase, and phospholipase A) aid in protein digestion. Pancreatic lipase acts on fats to produce glycerides, fatty acids, and glycerol; pancreatic amylase acts on starch to produce disaccharides. The pancreas also secretes sodium bicarbonate to neutralize the strongly acidic gastric contents as it enters the duodenum. The resultant mixture of acids and bases provides an optimal pH of 8.3 for activation of pancreatic enzymes.


Pancreatitis, which can be acute or chronic, is an inflammation of the pancreas with varying degrees of edema, hemorrhage, and necrosis. The damage can lead to fibrosis, stricture, and calcifications. Acute pancreatitis occurs when pancreatic ductal flow becomes obstructed and digestive enzymes escape from the pancreatic duct into surrounding tissue. Self-destruction of the pancreas produces edema, hemorrhage, and necrosis of pancreatic and surrounding tissue. Biochemical abnormalities and disruption of cardiopulmonary, renal, metabolic, and gastrointestinal (GI) function are likely. Pancreatitis has been associated with gallstones, alcoholism, surgical manipulation, abdominal trauma, abdominal vascular disease, heavy metal poisoning, infectious agents (viral, bacterial, mycoplasmal, parasitic), medications, and some allergic reactions. Pancreatitis also is associated with familial hyperlipidemia and can be induced by endoscopic retrograde cholangiopancreatography (ERCP). The majority of acute pancreatitis cases are mild, require a short hospitalization, and leave no long-term adverse effects. Severe acute pancreatitis involving multiple organ failure occurs in approximately 25% of cases but accounts for 98% of deaths associated with acute pancreatitis. Complications of acute pancreatitis include pancreatic abscess, hemorrhage, pancreatic pseudocyst, fistula formation, and transient hypoglycemia. Acute, life-threatening complications include renal failure, hemorrhagic pancreatitis, septicemia, adult respiratory distress syndrome (ARDS), shock, and disseminated intravascular coagulation (DIC).


Chronic pancreatitis is characterized by varying degrees of pancreatic insufficiency, which results in decreased production of enzymes and bicarbonate and malabsorption of fats and proteins. The digestion of fat is affected most severely. As a result, a high-fat content in the bowel stimulates water and electrolyte secretion, which produces diarrhea. The action of bacteria on fecal fat produces flatus, fatty stools (steatorrhea), and abdominal cramps. Often diabetes mellitus (DM) occurs as a result of chronic pancreatitis because of damage to the insulin-producing beta cells and resultant deficient insulin production. Chronic pancreatitis is also associated with complications of DM, chronic pain, maldigestion, pseudocysts, and bleeding.




Assessment








Diagnostic tests















Abdominal x-ray examination:


May show dilation of the small or large bowel and presence of pancreatic calcification in chronic pancreatitis.





Nursing diagnosis:


Acute pain

related to inflammatory process of the pancreas


Desired Outcomes: Within 6 hr of intervention, patient’s subjective perception of discomfort decreases, and it is controlled within 24 hr, as documented by pain scale. Nonverbal indicators, such as grimacing and splinting of abdominal muscles, are absent or diminished.






















ASSESSMENT/INTERVENTIONS RATIONALES
Assess for and document degree and character of patient’s discomfort. Devise a pain scale with patient, rating discomfort on a scale of 0 (no pain) to 10 (worst pain). Pain characteristics may signal varying problems (see Assessment section). Baseline and subsequent use of pain scale helps determine effectiveness of pain relief.
Assess patient’s previous responses to pain and previously effective pain relief measures. Consider possible cultural and spiritual influences. Patient’s previous history of pain and how well it was managed influence perceptions and trust in present pain relief measures. Some cultures allow less outward show of pain, whereas others do not prohibit expressions of pain.
Ensure that patient maintains limited activity or bedrest. Rest helps minimize pancreatic secretions and pain.
Maintain nothing by mouth (NPO) status, and monitor nasogastric (NG) tube function. NPO status and NG suction are initiated early in the course of illness to decrease stimulus for pancreatic secretions and reduce stress in the GI tract. After acute pain and ileus have resolved, the patient is given clear liquids and diet is advanced as tolerated.
Administer analgesics, steroids, histamine H2-receptor blockers, antiemetics, and other medications as prescribed. Be alert to patient’s response to medications, using pain scale.
< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 18, 2016 | Posted by in NURSING | Comments Off on Pancreatitis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access